CSI Market
Sign In | Register

Marinus Pharmaceuticals Inc (MRNS) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access MRNS quarterly Cash Flow →
The cash flow figures below highlight longer-term patterns in how Marinus Pharmaceuticals Inc manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
12 Months 		(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Operating Activities
Income-141.41
Depreciation & amortization1.05
Amortization of Other Assets2.25
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation15.56
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized0.00
Non Cash Operating Lease Expense Operating Activities0.25
Interest Expense Income On Lease Liabilities0.34
Increase Decrease In Contract With Customer Refund Liability-22.16
Accretion Of Revenue Interest Financing Debt-107.38
Operating Lease Impairment Loss-
Financing Costs Included In Interest Expense-
Increase Decrease In Contract With Customer Asset-
Increase Decrease In Prepaid Expense And Other Assets Noncurrent Assets Inventory And Accounts Receivable-
Income taxes43.70
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities2.11
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-118.00
Investing Activities
Capital Expenditures-0.12
Sale of Capital Items0.01
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payment For Equipment Deposit-
Payment For Property And Equipment Deposit-
Payments For Deposit And Property And Equipment-
Proceeds From Sale Of Priority Review Voucher107.38
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale, Maturity and Collection of Investments-28.50
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-28.61
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock25.80
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.83
Proceeds From Investor Deposit-
Proceeds From Equity Offerings Net64.48
Proceeds From Revenue Interest Financing Agreement Net Of Issuance Costs29.92
Payments Of Revenue Interest Financing Debt-0.04
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities26.63
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-118.11
Total Cash Flow-119.98
4 historic quarters locked

Sign in to unlock the full Marinus Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Marinus Pharmaceuticals Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001558370-24-002479

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License